5-Oxo Atorvastatin
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1391052-82-65-Oxo Atorvastatin

● In Stock

Catalogue No.:VE008728
CAS No.:1391052-82-6
Mol. Formula:C33H33FN2O5
Mol. Weight:556.62 g/mol

Additional information on CAS 1391052-82-6

Parent drug

Atorvastatin

IUPAC Name

(γR)-2-(4-Fluorophenyl)-γ-hydroxy-5-(1-methylethyl)-δ-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid

Synonyms

N/A

Smiles

CC(C)C1=C(C(=C(N1CCC(=O)CC(CC(=O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4

Description

5-Oxo Atorvastatin, CAS 1391052-82-6, is an oxidative impurity of the statin scaffold characterized by ketone formation at the 5-position of the pyrrole-based heptanoic acid side chain. Its molecular formula, C33H33FN2O5, corresponds to a molecular weight of 556.62 g/mol, consistent with a monooxygenated derivative of atorvastatin. Formation is typically associated with oxidative degradation during synthesis, storage, or stress exposure, rather than as a deliberate intermediate. Structural elucidation and trace-level quantification generally require LC-MS/MS, HRMS, and stability-indicating HPLC methods, with NMR used for definitive assignment. It is relevant to impurity profiling under pharmacopoeial and ICH Q3A/Q3B frameworks.

References

https://www.facebook.com/Drugscom. “Atorvastatin.” Drugs.com, Drugs.com, 2021, www.drugs.com/atorvastatin.html.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url